The effects of alpha-lipoic acid on diabetic myopathy
- 28 June 2017
- journal article
- research article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 41 (2) , 203-209
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Skeletal muscle as a therapeutic target for delaying type 1 diabetic complicationsWorld Journal of Diabetes, 2015
- Efficacy of α-lipoic acid in diabetic neuropathyExpert Opinion on Pharmacotherapy, 2014
- Diabetes and Alpha Lipoic AcidFrontiers in Pharmacology, 2011
- α-Lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscleBiochemical and Biophysical Research Communications, 2005
- New Insights on Oxidative Stress and Diabetic Complications May Lead to a “Causal” Antioxidant TherapyDiabetes Care, 2003
- Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 DiabetesEndocrine Reviews, 2002
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001
- Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.Diabetes Care, 1999
- Skeletal muscle in the diabetic mouse: Histochemical and morphometric analysisThe Anatomical Record, 1989
- Loss of fast-twitch isomyosins in skeletal muscles of the diabetic ratBiochemical Journal, 1984